OCDX Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 saus. 1970 @ 03:00):

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide...

Stats
Šios dienos apimtis	789 491
Vidutinė apimtis	1.01M
Rinkos kapitalizacija	0.00
EPS	$0.0612 ( 2022-05-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-42.28
ATR14	$0.509 (2.89%)

Insider Trading

Date	Person	Action	Amount	type
2022-05-27	Perez David Brian	Sell	8 576	Ordinary Shares, $0.00001 par value
2022-05-27	Hull Carl	Sell	41 172	Ordinary Shares, $0.00001 par value
2022-05-27	Dilsaver Evelyn S	Sell	5 200	Ordinary Shares, $0.00001 par value
2022-05-27	Carlyle Partners Vi Cayman Holdings, L.p.	Sell	118 106 000	Ordinary Shares, $0.00001 par value
2022-05-27	Carlyle Group Inc.	Sell	118 106 000	Ordinary Shares, $0.00001 par value

INSIDER POWER
-100.00
Last 11 transactions
Buy: 10 400 \| Sell: 261 566 948

Tūris Koreliacija

Ilgas: 0.02 (neutral)

Trumpas: -0.22 (neutral)

Signal:(49.304) Neutral

Ortho Clinical Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Ortho Clinical Koreliacija - Valiuta/Žaliavos

0.18
( neutral )

0.13
( neutral )

0.00
( neutral )

0.33
( neutral )

-0.08
( neutral )

0.08
( neutral )

Ortho Clinical Finansinės ataskaitos

Annual	2021
Pajamos:	$2.04B
Bruto pelnas:	$1.04B (50.71 %)
EPS:	$-0.0382

FY	2021
Pajamos:	$2.04B
Bruto pelnas:	$1.04B (50.71 %)
EPS:	$-0.0382

FY	2020
Pajamos:	$1.77B
Bruto pelnas:	$858.00M (48.58 %)
EPS:	$-0.978

FY	2019
Pajamos:	$1.80B
Bruto pelnas:	$879.10M (48.80 %)
EPS:	$-0.710

Financial Reports:

No articles found.

Ortho Clinical

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.